Drugs / G
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06470841 | Sep 2024 → Dec 2027 expected | acute myeloid leukemia | Navy General Hospital, Beijing | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06470841 ↗ |
| Route | Subcutaneous | “G 250ug/m2 subcutaneous injection qd d0-14” NCT06470841 ↗ |